BlackRock »

Xilio Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2026-06-30 $84k 8.8k 9.58

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for BlackRock

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
OrbiMed Advisors
Frazier Life Sciences Management
Stonepine Capital Management
Vanguard Capital Management
Sio Capital Management
Adage Capital Partners GP
Merck & Co
Renaissance Technologies
Morgan Stanley
Geode Capital Management
Citadel Advisors
Vanguard Fiduciary Trust
Bridgeway Capital Management
Two Sigma Investments

View all funds holding Xilio Therapeutics